Publicaciones (20) Publicaciones de ANA ISABEL CASTILLO VARON

2012

  1. Animal models of atherosclerosis

    Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 1-23

  2. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors

    British Journal of Pharmacology, Vol. 166, Núm. 4, pp. 1474-1489

2010

  1. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors

    Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440

2009

  1. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

    Brain Research, Vol. 1283, pp. 148-154

2008

  1. Cannabinoid CB 2 receptors in human brain inflammation

    British Journal of Pharmacology, Vol. 153, Núm. 2, pp. 277-285

  2. Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets

    Pediatric Research, Vol. 64, Núm. 6, pp. 653-658

  3. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers

    Molecular and Cellular Biology, Vol. 28, Núm. 11, pp. 3817-3829

2007

  1. Activation of the human immunodeficiency virus type I long terminal repeat by 1α,25-dihyfroxyvitamin D3

    Journal of Molecular Endocrinology, Vol. 38, Núm. 5-6, pp. 587-601

2006

  1. Characterization of vitamin D receptor ligands with cell-specific and dissociated activity

    MOLECULAR ENDOCRINOLOGY, Vol. 20, Núm. 12, pp. 3093-3104

  2. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor

    EMBO Reports, Vol. 7, Núm. 10, pp. 1030-1034

2004

  1. A Permissive Retinoid X Receptor/Thyroid Hormone Receptor Heterodimer Allows Stimulation of Prolactin Gene Transcription by Thyroid Hormone and 9-cis-Retinoic Acid

    Molecular and Cellular Biology, Vol. 24, Núm. 2, pp. 502-513

2000

  1. Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors

    Molecular and Cellular Biology, Vol. 20, Núm. 23, pp. 8793-8802

  2. Differentiation of lactotrope precursor GHFT cells in response to fibroblast growth factor-2

    Journal of Biological Chemistry, Vol. 275, Núm. 28, pp. 21653-21660

1999

  1. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1)

    MOLECULAR ENDOCRINOLOGY, Vol. 13, Núm. 7, pp. 1141-1154

  2. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1)

    Molecular Endocrinology, Vol. 13, Núm. 7, pp. 1141-1154

1998

  1. Activation of the Prolactin Gene by Peroxisome Proliferator-activated Receptor-α Appears to Be DNA Binding-independent

    Journal of Biological Chemistry, Vol. 273, Núm. 41, pp. 26652-26661

  2. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3- kinase dependent mechanism

    Oncogene, Vol. 16, Núm. 15, pp. 1981-1991

1997

  1. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells

    Endocrinology, Vol. 138, Núm. 12, pp. 5442-5451

  2. Growth factor ligands of tyrosine kinase receptors activate the Rous sarcoma virus promoter by a Ras- and Raf-dependent mechanism

    Gene, Vol. 188, Núm. 2, pp. 291-293

  3. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression

    DNA and Cell Biology, Vol. 16, Núm. 4, pp. 421-431